Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DTC Advertising Bill Would Mandate Deeper Rx Discounts For Medicaid

This article was originally published in The Pink Sheet Daily

Executive Summary

Legislation introduced by Sens. Wyden (D-Ore.) and Sununu (R-N.H.) is aimed at reducing federal program costs for the most commonly advertised drugs. The Pharmaceutical Advertising & Prudent Purchasing Act also would require a study on ways to reduce Medicare costs for drugs promoted through DTC campaigns.

You may also be interested in...



Sen. Kohl Joins Ranks Of DTC Legislation Sponsors

The Wisconsin Democrat's forthcoming bill would follow the "FDA Safety Act" and the "Pharmaceutical Advertising & Prudent Purchasing Act," both currently pending.

Sen. Kohl Joins Ranks Of DTC Legislation Sponsors

The Wisconsin Democrat's forthcoming bill would follow the "FDA Safety Act" and the "Pharmaceutical Advertising & Prudent Purchasing Act," both currently pending.

House Committee Adds $5.9 Mil. To FDA Budget For Drug Safety, Ad Review

The Appropriations Committee unanimously endorses a managers’ amendment that would provide FDA with an additional $5 mil. for “highest priority drug safety needs” and $884,000 for ad review division staff in fiscal year 2006.

Topics

UsernamePublicRestriction

Register

ID1132956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel